Real-World Treatment of Patients with Multiple Sclerosis per MS Subtype and Associated Healthcare Resource Use: An Analysis Based on 13,333 Patients in Germany
Crossref DOI link: https://doi.org/10.1007/s40120-019-00172-5
Published Online: 2019-12-12
Published Print: 2020-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Müller, Sabrina
Heidler, Tobias
Fuchs, Andreas
Pfaff, Andreas
Ernst, Kathrin
Ladinek, Gunter
Wilke, Thomas
Funding for this research was provided by:
Roche Pharma AG (NA)
Text and Data Mining valid from 2019-12-12
Version of Record valid from 2019-12-12
Article History
Received: 9 August 2019
First Online: 12 December 2019